Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 118

Results For "Import"

1737 News Found

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent
Biotech | April 25, 2022

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent

Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction


Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya
News | April 25, 2022

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya

April 25th is commemorated as World Malaria Day


NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency
Biotech | April 23, 2022

NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency

Heavy bleeding after giving birth is globally a leading cause of death in new mothers


CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


First ever nationwide epidemiological diabetes study released
Healthcare | April 22, 2022

First ever nationwide epidemiological diabetes study released

Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications


Saraq Hepatitis C kit receives CDSCO nod
Drug Approval | April 21, 2022

Saraq Hepatitis C kit receives CDSCO nod

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth


Evusheld significantly protected against symptomatic Covid-19 for at least six months
Biotech | April 21, 2022

Evusheld significantly protected against symptomatic Covid-19 for at least six months

Pre-exposure prevention trial reduced risk of symptomatic Covid-19, with no severe disease or Covid-19-related deaths in the Evusheld group


Veeva Vault CTMS launched at Bristol Myers Squibb
Medical Device | April 21, 2022

Veeva Vault CTMS launched at Bristol Myers Squibb

Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed


BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer
Drug Approval | April 20, 2022

BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer

The launch is yet another first of its kind innovation in India